Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD

European Journal of Ophthalmology

Volumn 9, Issue 3, 1999, Pages 217-230

  Algvere, Peep V ^a   Gouras, P ^b   Kopp, E Dafgård ^c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

Age related macular degeneration; Allograft rejection; Allograft tolerance; Immune privilege; RPE transplantation; Subretinal space

Indexed keywords

ADULT; AGED; ALLOGRAFT; ARTICLE; BLOOD RETINA BARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PIGMENT CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA PIGMENT EPITHELIOPATHY; SUBRETINAL NEOVASCULARIZATION; SURGICAL APPROACH; SURGICAL TECHNIQUE;

EID: 0032747848     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219900900310     Document Type: Article

References (34)

1. Streilein JW, Takeuchi M, Taylor AW. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Human Immunology 1997; 52: 138-43.
2. Ferguson TA, Griffith TS. Cell death and immune response: A lesson from the privileged. J Clin Immunol 1997; 17: 1-10.
3. Jiang LQ, Jorquera M, Streilein JW. Immunologic consequences of intraocular implantation of retinal pigment epithelium allografts. Exp Eye Res 1994; 58: 719-28.
4. El-Dirini AA, Wang H, Ogden TE, Ryan SJ. Retinal pigment epithelium implantation in the rabbit: technique and morphology. Graefe's Arch Clin Exp Ophthalmol 1992; 230: 292-300.
5. Berglin L, Gouras P, Sheng Y, Lavid J, Lin P-K, Cao H, Kjeldbye H. Tolerance of human fetal retinal pigment epithelium xenografts in monkey retina. Graefe's Arch Clin Exp Ophthalmol 1997; 235: 103-10.
6. Yamamoto S, Du J, Gouras P, Kjeldbye H. Retinal pigment epithelial transplants and retinal function in RCS rats. Invest Ophthalmol Vis Sci 1993; 34: 3068-75.
7. La Vail MM, Li L, Turner JE, Yasumura D. Retinal pigment epithelial cell transplantation in RCS rats: Normal metabolism in rescued photoreceptors. Exp Eye Res 1992; 55: 555-62.
8. Whitley SJO, Litchfield TM, Coffey PJ, Lund RD. Improvement of the pupillary light reflex of Royal College of Surgeons rats following RPE cell graft. Exp Neurol 1996; 140: 100-4.
9. Zhang X, Bok D. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Vis Sci 1998; 39: 1021-7.
10. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefe's Arch Clin Exp Ophthalmol 1994; 232: 707-16.
11. Algvere PV, Berglin L, Gouras P, Sheng Y, Dafgård Kopp E. Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy. Graefe's Arch Clin Exp Ophthalmol 1997; 235: 149-58.
12. Sheng Y, Gouras P, Cao H, et al. Patch transplants of human fetal retinal pigment epithelium in rabbit and monkey retina. Invest Ophthalmol Vis Sci 1995; 36: 381-90.
13. Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 1996; 37: 2485-94.
14. Lopez PF, Yan Q, Kohen L, et al. Retinal pigment epithelial wound healing in vivo. Arch Ophthalmol 1995; 113: 1437-46.
15. Crafoord S, Algvere P, Seregard S, Dafgård Kopp E. RPE allograft transplantation to the rabbit subretinal space. Invest Ophthalmol Vis Sci 1998; 39/4: S98.
16. Rezai KA, Semnani RT, Patel SC, Ernest JT, van Seventer GA. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation. Invest Ophthalmol Vis Sci 1997; 38: 2662-71.
17. Dafgård Kopp EME, Winter-Vernersson AM, Algvere PV. Expression of HLA class I and class II antigens in human fetal RPE cells. Invest Ophthalmol Vis Sci 1997; 38/4: S947.
18. Liversidge JM, Sewell HF, Forrester JV. Human retinal pigment epithelial cells differentially express MHC class II (HLA DP, DR, and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-y . Clin Exp Immunol 1988; 73: 489-94.
19. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992; 110: 1392-403.
20. Medawar P. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948; 29: 58.
21. Niederkorn JY, Streilein JW. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed type hypersensitivity but normal cytotoxic T lymphocyte responses. J Immunol 1983; 131: 2670-6.
22. Wilbanks GA, Streilein JW. Studies on the induction of anterior chamber associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol 1991; 146: 2610-7.
23. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol 1991; 146: 3018-24.
24. Hooper B, Bora NS, Kaplan HJ, Ferguson TA. Inhibition of lymphocyte proliferation by resident ocular cells. Curr Eye Res 1991; 10: 363-72.
25. Wilbanks G, Streilein JW. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor beta. Eur J Immunol 1992; 22: 165-74.
26. Ferguson TA, Fletcher S, Herndon JM, Griffith TS. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol 1995; 155: 1746-56.
27. Bora NS, Gobelman CL, Atkinson JP, Pepose JS, Kaplan HJ. Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 1993; 34: 3579-84.
28. Apte R, Niederkorn JY. Isolation of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol 1996; 156: 2667-73.
29. Knisely TL, Anderson TM, Sherwood ME, Flotte TJ, Albert DM, Granstein RD. Morphologic and ultrastructural examination of I-A+ cells in murine iris. Invest Ophthalmol Vis Sci 1991; 32: 2423-31.
30. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. FAS ligand induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-92.
31. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for DC95 ligand in preventing graft rejection. Nature 1995; 377: 630-2.
32. Grisanti S, Ishioka M, Kosiewicz M, Jiang LQ. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants. Invest Ophthalmol Vis Sci 1997; 38: 1619-26.
33. Hoffman LM, Maguire AM, Bennet J. Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest Ophthalmol Vis Sci 1997; 38: 2224-33.
34. Gouras P, Algvere P: Retinal cell transplantation in the macula: New techniques. Vision Res 1996; 36: 4121-5.